Seeking Alpha

Acorda Therapeutics (ACOR): Q2 EPS of $0.27 in-line. Revenue of $75.7M (+15.9% Y/Y) beats by...

Acorda Therapeutics (ACOR): Q2 EPS of $0.27 in-line. Revenue of $75.7M (+15.9% Y/Y) beats by $3.1M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|